Duopharma Biotech is partnering with RenalWorks Malaysia Sdn Bhd, a subsidiary of Singapore-based RenalWorks Pte Ltd to enhance dialysis services through the provision of the proprietary RenalGenie Electronic Health Record (EHR) dialysis software.
The software was formally introduced to healthcare providers following the recent signing of an agreement between Duopharma (M) Sendirian Berhad, a subsidiary of Duopharma Biotech Berhad and RenalWorks Malaysia Sdn Bhd, whereby Duopharma Biotech will be the Exclusive Sales and Marketing Partner for RenalGenie EHR dialysis software in Malaysia, with potential expansion to other ASEAN markets in the future.
Innovated with the needs of independent, group and hospital-based dialysis facilities of all sizes in mind, the highly-scalable and adaptable RenalGenie EHR dialysis software focuses on streamlining data flows, and strengthening patient care and compliance, while ensuring that healthcare facilities can provide the highest standards of service with optimised operational efficiency.
The all-in-one healthcare facilities management software taps on the latest cloud-based accessibility and mobile technologies to enable remote management and overcome the challenges of installing conventional dialysis EHR systems.
Via a comprehensive and centralised database recording up-to-date patient health data, healthcare providers are empowered with informed decision-making, with optimised healthcare facilities management and care coordination and a user-friendly interface.
The RenalGenie EHR dialysis software also conforms to international standards for quality, safety, security and privacy, and is certified under ISO 9001:2015 Quality Management System for design, development, manufacture, distribution and service of administrative, financial and management support for clinical software.
The software is also in accordance with the USA’s Health Insurance Portability and Accountability Act (HIPAA) and the European Union’s General Data Protection Regulation (GDPR) requirements.
“As a Malaysian healthcare company with a vision of ‘Providing Smarter Solutions for a Healthier Life’, Duopharma Biotech is always on the lookout for potential partners with innovations to support better healthcare outcomes. While it is crucial for the Ministry of Health and other stakeholders to work on preventing disease, it is also critical to take a long-term view on improving healthcare outcomes by improving treatment for existing patients. In terms of dialysis, Malaysia is unfortunately looking at an uptick in kidney disease and kidney failure patients in the years to come, so it is important to lay the groundwork now for healthcare systems to support this future need. In addition, implementation of the RenalGenie EHR dialysis software is also in line with national efforts to expand digitalisation for improving healthcare service delivery, and in turn, elevate outcomes,” said Leonard Ariff Abdul Shatar, Group Managing Director, Duopharma Biotech Berhad.
Elaborating on the development of the RenalGenie EHR dialysis software, Chan Wai Chuen, Founder and Managing Director of RenalWorks Pte Ltd, said, “We innovated RenalGenie to achieve new standards in patient care, safety and outcomes with comprehensive treatment functionalities to address key pain points and data gaps in dialysis care. With RenalGenie, healthcare facilities can substantially reduce operational costs by streamlining workflow processes and improve revenue by applying our proprietary automated billing algorithms and scheduler to optimise healthcare facilities’ capacity utilisation. Indeed, our survey at the Malaysian Society of Nephrology’s conference in July 2023 found that 44% of respondents rely solely on paper-based processes in their healthcare facilities, whilst 37% rely on a combination of paper-based and software processes. This indicates a high level of unmet demand for dialysis-focused EHR software to enhance clinical, billing and workflow processes.”
Chan said the RenalGenie EHR “marks a significant milestone in RenalWorks’ mission to democratise dialysis EHR software to overcome the technological divide between dialysis centres in developed and middle-income countries. This goal is realised by eliminating expenses related to software licenses, hardware procurement, installations and complex integrations typical of current EHR software. By leveraging advancements in cloud computing, the widespread use of the web, and the adoption of mobile devices, RenalGenie offers an affordable, accessible, and easily adoptable EHR solution, particularly for middle-income markets. RenalGenie distinguishes itself with its capability for remote setup in any healthcare facilities, regardless of its location or size, within a week. This allows healthcare facilities to quickly realise value from efficient patient and healthcare facilities management, and administrative tasks. Its integrated patient database empowers doctors to remotely monitor and manage patients and aids clinical teams in collaborating and making informed, timely decisions. This functionality is crucial in improving patient outcomes and minimising the costs and risks associated with misdiagnosis or delayed treatment.”
